Suppr超能文献

多巴胺能系统在反复给予苯环利定预处理的小鼠中对苯环利定诱导的位置偏爱行为的影响。

Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly.

作者信息

Noda Y, Miyamoto Y, Mamiya T, Kamei H, Furukawa H, Nabeshima T

机构信息

Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University School of Medicine, Japan.

出版信息

J Pharmacol Exp Ther. 1998 Jul;286(1):44-51.

PMID:9655840
Abstract

In the conditioned place preference test, phencyclidine (PCP) produces place aversion in naive rats, whereas PCP produces place preference in rats treated with PCP repeatedly. Although the PCP-induced place aversion is thought to involve the serotonergic system, the mechanisms of the PCP-induced place preference are unclear. We investigated whether the dopaminergic system is involved in place preference induced by PCP in mice repeatedly treated with PCP, because it is well known that the dopaminergic system plays an important role in the rewarding effect of drugs. PCP (2-8 mg/kg s.c.) induced a dose-dependent place aversion in naive mice, whereas PCP (2-8 mg/kg s.c.) induced a dose-dependent place preference in mice pretreated with PCP (10 mg/kg/day s.c.) for 28 days. The place preference induced by PCP (8 mg/kg s.c.) was attenuated significantly by alpha-methyl-rho-tyrosine (100 mg/kg i.p.), a tyrosine hydroxylase inhibitor, 6-hydroxydopamine (100 micrograms/mouse i.c.v.), a dopaminergic neurotoxin, and R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benza zepine (0.5 mg/kg s.c.), a dopamine D1 receptor antagonist. These agents themselves produced neither the place preference nor aversion. In contrast to the attenuating effects of these agents, N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (30 mg/kg i.p.), a noradrenergic neurotoxin, ritanserin (1 mg/kg i.p.), a serotonin2 receptor antagonist, and (-) sulpiride (50 and 100 mg/kg i.p.), a dopamine D2 receptor antagonist, failed to affect the PCP-induced place preference. In mice pretreated with methamphetamine (1 mg/kg/day s.c.) for 14 days, PCP (8 mg/kg s.c.) induced the place preference, but not aversion. These results demonstrate that the PCP-induced place preference depends on dopaminergic, but not on serotonergic and noradrenergic, neuronal systems and suggest a role for D1 receptors in the mediation of the PCP-induced place preference.

摘要

在条件性位置偏爱试验中,苯环利定(PCP)在未接触过的大鼠中引起位置厌恶,而在反复接受PCP处理的大鼠中则引起位置偏爱。虽然PCP诱导的位置厌恶被认为与血清素能系统有关,但PCP诱导位置偏爱的机制尚不清楚。我们研究了多巴胺能系统是否参与了反复接受PCP处理的小鼠中PCP诱导的位置偏爱,因为众所周知多巴胺能系统在药物的奖赏效应中起重要作用。PCP(2 - 8毫克/千克,皮下注射)在未接触过的小鼠中诱导出剂量依赖性的位置厌恶,而PCP(2 - 8毫克/千克,皮下注射)在预先用PCP(10毫克/千克/天,皮下注射)处理28天的小鼠中诱导出剂量依赖性的位置偏爱。PCP(8毫克/千克,皮下注射)诱导的位置偏爱被α-甲基-对-酪氨酸(100毫克/千克,腹腔注射)(一种酪氨酸羟化酶抑制剂)、6-羟基多巴胺(100微克/小鼠,脑室内注射)(一种多巴胺能神经毒素)和R-(+)-7-氯-8-羟基-3-甲基-1-苯基-2,3,4,5-四氢-1H-3-苯并氮杂卓(0.5毫克/千克,皮下注射)(一种多巴胺D1受体拮抗剂)显著减弱。这些药物本身既不产生位置偏爱也不产生位置厌恶。与这些药物的减弱作用相反,N-(2-氯乙基)-N-乙基-2-溴苄胺(30毫克/千克,腹腔注射)(一种去甲肾上腺素能神经毒素)、利坦色林(1毫克/千克,腹腔注射)(一种5-羟色胺2受体拮抗剂)和(-)舒必利(50和100毫克/千克,腹腔注射)(一种多巴胺D2受体拮抗剂)未能影响PCP诱导的位置偏爱。在用甲基苯丙胺(1毫克/千克/天,皮下注射)处理14天的小鼠中,PCP(8毫克/千克,皮下注射)诱导出位置偏爱,但没有引起位置厌恶。这些结果表明,PCP诱导的位置偏爱依赖于多巴胺能神经元系统,而非血清素能和去甲肾上腺素能神经元系统,并提示D1受体在介导PCP诱导的位置偏爱中起作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验